SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

News > Markets

Read more breaking news

 

 
News in brief

Florida-based portfolio company Wellnext acquires collagen brand NeoCell

Post a comment
Adi Menayang

By Adi Menayang

09-Aug-2017
Last updated on 09-Aug-2017 at 18:03 GMT2017-08-09T18:03:12Z

Portfolio company Wellnext acquires collagen brand NeoCell

Wellnext announced it is acquiring the 20-year-old company NeoCell, which specializes in collagen-based supplements for joint, bone, and muscle health.

The acquisition fits in Wellnext’s series of strategic moves, by way of acquisitions, to expand its presence in the dietary supplement industry. Other recent acquisitions include Nutri-Health Supplements and Sedona Labs back in 2014. Financial details were not disclosed.

"NeoCell complements Wellnext's portfolio of brands, expanding it into the fast-growing collagen category while diversifying the company's product category focus," Jose Minski, CEO of Wellnext, said in a press release. "We are excited to work with NeoCell's industry-leading products for beauty, bone and joint health."

Wellnext is a portfolio company owned by an affiliate of Ft. Lauderdale-based private equity firm WM Partners, LP, which focuses on investing in middle-market companies in the health and wellness sector.

With the acquisition of NeoCell, Wellnext now has a portfolio of supplements for joint, bone, and muscle health using formulas based on ingredients such as collagen, biotin and hyaluronic acid.

"We are very excited to partner with Wellnext and gain the support of its operational and commercial capabilities to further expand NeoCell," said Sarah Quadri, NeoCell's Chief Operating Officer. "We are confident that Wellnext will provide unique manufacturing, product development, and market expansion capabilities to support NeoCell's next phase of growth."

PNC Business Credit, a division of PNC Bank, and McLarty Capital Partners were the lead funding agents. Pepper Hamilton LLP served as Wellnext's legal advisor on the transaction.

Post a comment

Comment title *
Your comment *
Your name *
Your email *

We will not publish your email on the site

I agree to Terms and Conditions

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Related products